Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
© 2023 Huang et al..
Purpose: The emergence of genomic targeted therapy has improved the prospects of treatment for breast cancer (BC). However, genetic testing relies on invasive and sophisticated procedures.
Patients and Methods: Here, we performed ultrasound (US) and target sequencing to unravel the possible association between US radiomics features and somatic mutations in TNBC (n=83) and non-TNBC (n=83) patients. Least absolute shrinkage and selection operator (Lasso) were utilized to perform radiomic feature selection. The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was utilized to identify the signaling pathways associated with radiomic features.
Results: Thirteen differently represented radiomic features were identified in TNBC and non-TNBC, including tumor shape, textual, and intensity features. The US radiomic-gene pairs were differently exhibited between TNBC and non-TNBC. Further investigation with KEGG verified radiomic-pathway (ie, JAK-STAT, MAPK, Ras, Wnt, microRNAs in cancer, PI3K-Akt) associations in TNBC and non-TNBC.
Conclusion: The pivotal network provided the connections of US radiogenomic signature and target sequencing for non-invasive genetic assessment of precise BC treatment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Breast cancer (Dove Medical Press) - 15(2023) vom: 20., Seite 461-472 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Huang, Yunxia [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Revised 18.07.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.2147/BCTT.S408997 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359576567 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM359576567 | ||
003 | DE-627 | ||
005 | 20231226081156.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2147/BCTT.S408997 |2 doi | |
028 | 5 | 2 | |a pubmed24n1198.xml |
035 | |a (DE-627)NLM359576567 | ||
035 | |a (NLM)37456987 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Huang, Yunxia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 18.07.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 Huang et al. | ||
520 | |a Purpose: The emergence of genomic targeted therapy has improved the prospects of treatment for breast cancer (BC). However, genetic testing relies on invasive and sophisticated procedures | ||
520 | |a Patients and Methods: Here, we performed ultrasound (US) and target sequencing to unravel the possible association between US radiomics features and somatic mutations in TNBC (n=83) and non-TNBC (n=83) patients. Least absolute shrinkage and selection operator (Lasso) were utilized to perform radiomic feature selection. The Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was utilized to identify the signaling pathways associated with radiomic features | ||
520 | |a Results: Thirteen differently represented radiomic features were identified in TNBC and non-TNBC, including tumor shape, textual, and intensity features. The US radiomic-gene pairs were differently exhibited between TNBC and non-TNBC. Further investigation with KEGG verified radiomic-pathway (ie, JAK-STAT, MAPK, Ras, Wnt, microRNAs in cancer, PI3K-Akt) associations in TNBC and non-TNBC | ||
520 | |a Conclusion: The pivotal network provided the connections of US radiogenomic signature and target sequencing for non-invasive genetic assessment of precise BC treatment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a radiomics | |
650 | 4 | |a signaling pathway | |
650 | 4 | |a somatic mutation | |
650 | 4 | |a triple-negative breast cancer | |
700 | 1 | |a Guo, Yi |e verfasserin |4 aut | |
700 | 1 | |a Xiao, Qin |e verfasserin |4 aut | |
700 | 1 | |a Liang, Shuyu |e verfasserin |4 aut | |
700 | 1 | |a Yu, Qiang |e verfasserin |4 aut | |
700 | 1 | |a Qian, Lang |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Jin |e verfasserin |4 aut | |
700 | 1 | |a Le, Jian |e verfasserin |4 aut | |
700 | 1 | |a Pei, Yuchen |e verfasserin |4 aut | |
700 | 1 | |a Wang, Lei |e verfasserin |4 aut | |
700 | 1 | |a Chang, Cai |e verfasserin |4 aut | |
700 | 1 | |a Chen, Sheng |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Shichong |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Breast cancer (Dove Medical Press) |d 2009 |g 15(2023) vom: 20., Seite 461-472 |w (DE-627)NLM222646233 |x 1179-1314 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2023 |g day:20 |g pages:461-472 |
856 | 4 | 0 | |u http://dx.doi.org/10.2147/BCTT.S408997 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2023 |b 20 |h 461-472 |